Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Emory S. Olive"'
Publikováno v:
Telemedicine journal and e-health : the official journal of the American Telemedicine Association. 15(1)
Chronic illnesses account for approximately 75% of all healthcare costs in the United States today, resulting in functional limitations and loss of independence, as well as increased medical expenditures. The elderly population is at a higher risk fo
Autor:
Samuel C. Bukantz, James M. Hubbard, Richard F. Lockey, Irene A. Baird-Warren, Paul C. Turkeltaub, Emory S. Olive
Publikováno v:
Journal of Allergy and Clinical Immunology. 86:775-780
One thousand four hundred ten (44%) of the 3236 subjects in the Hymenoptera venom study accepted venom immunotherapy (VIT). Time to maintenance averaged 95 days, and the largest number achieved maintenance (147 subjects, 10.4%) at day 56. Ninety-two
Publikováno v:
Telemedicine & e-Health; Jan2009, Vol. 15 Issue 1, p31-38, 8p
Autor:
Samuel C. Bukantz, Irene A. Baird-Warren, Paul C. Turkeltaub, Emory S. Olive, Richard F. Lockey, Christine A. Olive
Publikováno v:
The Journal of allergy and clinical immunology. 84(6 Pt 1)
Data are summarized in this Hymenoptera venom study (HVS) article on the safety of skin testing with venom extracts. Of the 3236 subjects studied, 89% had experienced an historical sting systemic reaction (SSR). Seventy-four percent of all subjects a
Autor:
Samuel C. Bukantz, Christine A. Olive, Paul C. Turkeltaub, Richard F. Lockey, Emory S. Olive, Irene A. Baird-Warren, Brett C. Peppe
Publikováno v:
The Journal of allergy and clinical immunology. 82(3 Pt 1)
The Hymenoptera venom study, a study based on case histories, skin test results and adverse reactions, immunotherapy and adverse reactions, and treatment efficacy, for 3236 Hymenoptera-allergic subjects, was begun in 1979 after the Food and Drug Admi